Significance of estrogen receptor 1 (ESR-1) gene imbalances in colon and hepatocellular carcinomas based on tissue microarrays analysis

Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer

(2009) Marcus C. Tan et al.   AMERICAN JOURNAL OF SURGERY

Breast cancer biomarkers and HER2 testing after 10 years of anti-HER2 therapy

(2009) J.S. Ross   DRUG NEWS & PERSPECTIVES

Outcome of Patients With Early-Stage Breast Cancer Treated With Doxorubicin-Based Adjuvant Chemotherapy As a Function ofHER2andTOP2AStatus

(2009) Raymond Tubbs et al.   JOURNAL OF CLINICAL ONCOLOGY

Lack of Association between the Functional Polymorphisms in the Estrogen-Metabolizing Genes and Risk for Hepatocellular Carcinoma

(2008) X. Yuan et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

ERBB2 influences the subcellular localization of the estrogen receptor in tamoxifen-resistant MCF-7 cells leading to the activation of AKT and RPS6KA2

(2008) S. Pancholi et al.   ENDOCRINE-RELATED CANCER

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

(2008) Stephen Chia et al.   JOURNAL OF CLINICAL ONCOLOGY

ESR1 gene amplification in breast cancer: a common phenomenon?

(2008) Anne Vincent-Salomon et al.   NATURE GENETICS

Conflicting evidence on the frequency of ESR1 amplification in breast cancer

(2008) Donna G Albertson   NATURE GENETICS